Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 285 citing Fletcher: Carcinoembryonic antigen. (0.11 sec) 

[BOOK] Medical decision making


HC Sox, MA Blatt, MC Higgins, KI Marton… - 2006 - books.google.com
Copyright © 2007 by American College of Physicians. All rights reserved. No part of this
publi- cation may be reproduced in any form by any means (electronic, mechanical,
xerographic, or other) or held in any information storage or retrieval systems without prior ...
Cited by 930 - Related articles

Use of methodological standards in diagnostic test research. Getting better but still …


MC Reid, MS Lachs, AR Feinstein - Jama, 1995 - Am Med Assoc
OBJECTIVE--To determine the frequency and temporal changes in application of seven accepted
methodological standards for the evaluation of diagnostic tests. DATA SOURCES--A search
of the MEDLINE database yielded 1302 articles about diagnostic test studies, during a 16- ...
Cited by 574 - Related articles - BL Direct - All 3 versions

The STARD statement for reporting studies of diagnostic accuracy: explanation and …

- clinchem.org
PM Bossuyt, JB Reitsma, DE Bruns, CA Gatsonis … - Clinical …, 2003 - Am Assoc Clin Chem
Cited by 537 - Related articles - BL Direct - All 23 versions

Meta-analysis of Pap test accuracy


MT Fahey, L Irwig, P Macaskill - American Journal of Epidemiology, 1995 - Oxford Univ Press
A literature search identified 62 studies published by August 1992 comparing Papanicolaou
(Pap) test results with histology. Critical appraisal revealed that 82% of these had potential for
verification bias and that only 37% stated that cytology and histology were independently ...
Cited by 488 - Related articles - BL Direct - All 3 versions

Biases in the assessment of diagnostic tests


CB Begg - Stat Med, 1987 - interscience.wiley.com
Diagnostic tests are traditionally characterized by simple measures of efficacy such as the sensitivity
and the specificity. These measures, though widely recognized and easy to understand, are
subject to definitional arbitrariness. Moreover, studies constructed to estimate the ...
Cited by 345 - Related articles - All 3 versions

Development of antibodies against p53 in lung cancer patients appears to be …

- aacrjournals.org [PDF] 
SF Winter, JD Minna, BE Johnson, T Takahashi, AF … - Cancer Research, 1992 - AACR
Development of Antibodies against p53 in Lung Cancer Patients Appears to Be ... Dependent
on the Type of p53 Mutation ... Stefan F. Winter,1 John D. Minna, Bruce E. Johnson, Takashi
Takahashi,2 Adi F. Gazdar, and David P. Carbone3 ... Simmons Cancer Center, ...
Cited by 244 - Related articles - All 3 versions

Recommended colorectal cancer surveillance guidelines by the American Society …

- ascopubs.org
CE Desch, AB Benson III, TJ Smith, PJ Flynn, … - Journal of Clinical …, 1999 - jco.ascopubs.org
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... From the American Society of
Clinical Oncology. (ASCO) Colorectal Cancer Surveillance Panel; CED and ABB are co- ...
Cited by 170 - Related articles - BL Direct - All 6 versions

Clinical epidemiological quality in molecular genetic research: the need for …


ST Bogardus Jr, J Concato, AR Feinstein - Jama, 1999 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context A genetic basis has been identified for ...
Cited by 139 - Related articles - BL Direct - All 4 versions

Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

- clinchem.org
MJ Duffy - Clinical Chemistry, 2001 - Am Assoc Clin Chem
Background: Carcinoembryonic antigen (CEA) is one of the most widely used tumor markers
worldwide. Its main application is mostly in gastrointestinal cancers, especially in colorectal
malignancy. Although in use for almost 30 years, the clinical value of CEA in colorectal ...
Cited by 133 - Related articles - BL Direct - All 5 versions

Clinical utility of biochemical markers in colorectal cancer European Group on …


MJ Duffy, A Van Dalen, C Haglund, L Hansson, R … - European Journal of …, 2003 - Elsevier
In recent years, numerous serum and cell/tissue-based markers have been described for colorectal
cancer (CRC). The aim of this article was to provide guidelines for the routine clinical use of some
of these markers. Lack of sensitivity and specificity preclude the use of any available ...
Cited by 131 - Related articles - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google